June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Characterization of development and Repeatability of Tear breakup shapes
Author Affiliations & Notes
  • Deborah Awisi-Gyau
    indiana university, school of optometry, Bloomington, Indiana, United States
  • Carolyn G Begley
    indiana university, school of optometry, Bloomington, Indiana, United States
  • Richard J Braun
    University of Delaware, Delaware, United States
  • Rayanne A Luke
    University of Delaware, Delaware, United States
  • Anna F Tichenor
    indiana university, school of optometry, Bloomington, Indiana, United States
  • Peter Ewen King-Smith
    Ohio State University, Ohio, United States
  • Footnotes
    Commercial Relationships   Deborah Awisi-Gyau, None; Carolyn Begley, None; Richard Braun, None; Rayanne Luke, None; Anna Tichenor, None; Peter King-Smith, None
  • Footnotes
    Support  NEI grant R01EY021794 (CB)
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1392. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Deborah Awisi-Gyau, Carolyn G Begley, Richard J Braun, Rayanne A Luke, Anna F Tichenor, Peter Ewen King-Smith; Characterization of development and Repeatability of Tear breakup shapes. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1392.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Tear breakup(TBU) plays a critical role in dry eye disease(Craig,Oc Surf,2017).Patterns of TBU are associated with dry eye subtypes and symptoms(Yokoi et al.,Am JOphthalmol,2017).In this study, we quantify the origin,development of shapes, areas, locations of TBU, their repeatability and TBU thinning rates in normal subjects to understand the natural process of TBU previous to DED.

Methods : Fluorescein was instilled into lefteye of 15normal subjects and kept open as long as possible in 3consecutive Sustained TeAR Exposure trials and recorded. Frames were extracted from videos of the tearfilm and the first three areas of TBU identified. Properties of location,shape, including area, orientation and circularity were quantified and thinning rate was calculated. Areas of TBU were categorized as spots(circularity>0.6) and streaks(circularity<0.6) by their shape at end of each trial.Repeatability of areas of TBU over the 3 trials were determined.

Results : 45 TBU cases were examined.Average percent area(±SD) of TBU in superior, central and inferior of the exposed corneal surface were 3.47%(3.97), 4.33%(3.03) and 2.91%(3.01)respectively. Average(±SD)percentage overlap between the 3 consecutive trials in superior, central and inferior regions were 0.62%(1.44), 0.62%(1.28)and 0.31%(0.72)respectively. Almost all TBU(96%) cases started as spots and 60% grew into streaks(Fig 1).18 and 27 cases were identified as spots and streaks respectively. Range of thinning rates(reduction in pixel intensity) for all areas of TBU was 0.9%PI/sec to 13.9 %PI/sec, with a median rate of 5.1%PI/sec for streaks and 2.7%PI/sec(Fig 2) for spots.Spots tended to have a smaller area, 0.07mm2 (0.10) compared to streaks, 0.47mm2(0.53). For streaks identified, 10 were oriented horizontally(0 to 300),8 were oblique(30 to 600) and 10 were vertical(60 to 900).

Conclusions : TBU in these normal subjects occurred in all corneal regions with relatively low repeatability in location. Most TBU areas began as small spots,with streaks expanding from spots in all orientations. Thinning rates suggest evaporation as a mechanism involved in the development of most areas of TBU, but more rapid(<4sec)TBU may also involve surface tension effects.

This is a 2020 ARVO Annual Meeting abstract.

 

Change in circularity of TBU streaks from beginining to end of trial

Change in circularity of TBU streaks from beginining to end of trial

 

Thinning rates in streak and spot TBU

Thinning rates in streak and spot TBU

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×